tiprankstipranks
Nuo Therapeutics Inc (AURX)
:AURX
US Market

Nuo Therapeutics (AURX) Income Statement

Compare
11 Followers

Nuo Therapeutics Income Statement

Last quarter (Q3 2024), Nuo Therapeutics's total revenue was $370.95K, an increase of 59.73% from the same quarter last year. In Q3, Nuo Therapeutics's net income was $-578.17K. See Nuo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 608.52K$ 112.25K$ 0.00$ 0.00$ 146.18K
Gross Profit
$ 482.43K$ 93.04K$ 0.00$ 0.00$ 31.56K
Operating Expenses
$ 3.65M$ 3.41M$ 90.67K$ 378.06K$ 1.00M
Depreciation and Amortization
$ 105.26K$ 74.08K$ 90.67K$ 89.86K$ 89.86K
EBITDA
$ -3.06M$ -3.10M$ 0.00$ -288.20K$ -879.34K
Operating Income
$ -3.17M$ -3.32M$ -90.67K$ -378.06K$ -969.20K
Other Income/Expenses
$ -3.16K$ 148.86K$ 0.00$ 287.19K$ -225.70K
Pretax Income
$ -3.17M$ -3.17M$ -90.67K$ -90.87K$ -1.19M
Net Income
$ -3.17M$ -3.03M$ -90.67K$ -139.26K$ -1.42M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.08$ -0.08$ 0.00$ -0.01$ -0.06
Diluted EPS
$ -0.08$ -0.08$ 0.00$ -0.01$ -0.06
Weighted Average Shares Outstanding
42.08M 40.00M 30.30M 25.69M 23.72M
Weighted Average Shares Outstanding (Diluted)
42.08M 40.00M 30.30M 27.31M 23.72M
Currency in USD

Nuo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis